Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Acta Pol Pharm ; 74(3): 995-1000, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-29513970

RESUMO

Tuberculosis (TB) is an infectious disease that is communicable from one person to another. Pakistan stands forefront among few unfortunate countries that still have heavy burden of TB infection. Being a developing country, TB patients in Pakistan have to face different socio-economic constraints that upset life of the patients as well as their families. A cross sectional survey was conducted in three selected districts, Lodharan, Bahawalpur and Bahawalnagar during February 2011 to June 2011. From three hundred selected patients 210 Were enrolled in study after receiving written consents. Data were collected though structured questionnaire and verbal-interviews and statistically analyzes by using the univariate analysis. The survey results showed that the low educational status (p < 0.0012, CI 95%), unawareness of disease (88.7%), crowded population (p = 0.0000, CI, 95%), poverty, high treatment cost and distant access to public health facilities were directly related to prevalence of TB. Different disease related constraints including poor attitude of family members, colleagues, society and even health care professionals (p = 0.0000, CI 95%) were also found to be major social factors leading to non-compliance and denial of TB treatment. Socio-economic constraints such as low literacy rate, unemployment, unawareness of disease, high treatment cost, poor attitude of family, society and healthcare professionals were directly related to noncompliance and should be given high priority consideration for achieving better TB management and mitigation.


Assuntos
Antituberculosos/uso terapêutico , Acessibilidade aos Serviços de Saúde , Adesão à Medicação , Fatores Socioeconômicos , Tuberculose/tratamento farmacológico , Antituberculosos/efeitos adversos , Antituberculosos/economia , Estudos Transversais , Custos de Medicamentos , Escolaridade , Relações Familiares , Feminino , Pesquisas sobre Atenção à Saúde , Conhecimentos, Atitudes e Prática em Saúde , Acessibilidade aos Serviços de Saúde/economia , Humanos , Entrevistas como Assunto , Masculino , Paquistão/epidemiologia , Relações Médico-Paciente , Preconceito , Opinião Pública , Fatores de Risco , Vergonha , Estigma Social , Fatores de Tempo , Tuberculose/economia , Tuberculose/epidemiologia , Tuberculose/psicologia
2.
Acta Pol Pharm ; 73(6): 1659-1664, 2016 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-29634123

RESUMO

Tuberculosis (TB) is an infectious disease that is communicable from one person to another. Pakistan stands forefront among few unfortunate countries that still have heavy burden of TB infection. Being a developing country, TB patients in Pakistan have to face different socio-economic constraints that upset life of the patients as well as their families. A cross sectional survey was conducted in three selected districts, Lodharan, Bahawalpur and Bahawalnagar during February 2011 to June 2011. From three hundred selected patients 210 were enrolled in study after receiving written consents. Data were collected though structured questionnaire and verbal interviews and statistically analyzed by using the univariate analysis. The survey results showed that the low educational status (p < 0.0012, CI 95%), unawareness of disease (88.7%), crowded population (p =0.0000, CI, 95%), poverty, high treatment cost and distant access to public health facilities were directly related to prevalence of TB. Different disease related constraints including poor attitude of family members, colleagues, society and even health care professionals (p = 0.0000, CI 95%) were also found to be major social factors leading to non-compliance and denial of TB treatment. Socio-economic constraints such as low literacy rate, unemployment, unawareness of disease, high treatment cost, poor attitude of family, society and health care professionals were directly related to noncompliance and should be given high priority consideration for achieving better TB management and mitigation.


Assuntos
Custos de Cuidados de Saúde , Acessibilidade aos Serviços de Saúde/economia , Cooperação do Paciente , Tuberculose/terapia , Adulto , Estudos Transversais , Países em Desenvolvimento , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Paquistão , Pobreza , Prevalência , Fatores Socioeconômicos , Inquéritos e Questionários , Tuberculose/economia , Adulto Jovem
3.
Acta Pol Pharm ; 73(5): 1123-1128, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-29638052

RESUMO

A simple and cost effective RPLC-UV bio-analytical method was developed and used for tenoxicam quantification on ODS Hypersil C-18 column using classical liquid-liquid extraction technique for sample preparation. Acetonitrile was used as precipitating agent for plasma proteins and supernatant was taken for injection without any further modification. The bio-analytical method depends upon isocratic elution using binary mixture of aqueous 0.1 M potassium dihydrogen phosphate and acetonitrile in 6 : 4 ratio. The pH of mobile phase was adjusted to 2.8 which favor tenoxicam to remain undissociated throughout the analysis. The optimized flow rate of 1.0 mL/min provided proper separation of peaks and column clean up within 5 min. The UV detection was achieved at 381 nm and 4.29 min. Reproducible calibration curve gave 0.325 µg/mL LOQ, linear dynamic range from 0.325 to 20 µg/mL and recovery from plasma was 98.5% with %CV 0.2314 achieved. After validation, the method was applied in pharmacokinetic study in healthy human volunteers (n = 8). The pharmacokinetic parameters were evaluated using kinetica version 4.1.1. The values of C. and area under curve for current study were 1.776 ± 0.003 pg/mL and 179.97 ± 0.0681 (mean ± SEM) pg x h/mL. The values of t, and volume of distribution for tenoxicam in current study were 74.103 0.167 h (mean ± SEM) and 11.962 ± 0.0677 L/kg (mean ± SEM), respectively. This method was simple, sensitive and successfully applied in pharmacokinetic studies. It can be extended to bioequivalence studies and evaluation of tenoxicam in different clinical situations.


Assuntos
Cromatografia Líquida de Alta Pressão/métodos , Cromatografia de Fase Reversa/métodos , Piroxicam/análogos & derivados , Análise Custo-Benefício , Estabilidade de Medicamentos , Humanos , Piroxicam/sangue , Piroxicam/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA